ClearSign Technologies Corporation Announces Proposed Public Offering of Common Stock

TULSA, OK / ACCESS Newswire / Might 28, 2026 / ClearSign Applied sciences Company (NASDAQ:CLIR) (“ClearSign” or the “Firm”), a frontrunner in superior combustion and sensing applied sciences that assist industrial operators dramatically cut back emissions, improve effectivity and assist using cleaner fuels together with hydrogen, right this moment proclaims that it’s proposing to promote shares of its frequent inventory in an underwritten public providing (the “Public Providing”). The entire shares within the Public Providing are to be bought by ClearSign. ClearSign intends to grant the underwriter a 30-day choice to buy as much as a further 15% of the shares of frequent inventory provided within the Public Providing on the Public Providing value, much less the underwriting low cost.

ClearSign intends to make use of the web proceeds from the Public Providing for working capital, analysis and improvement, advertising and gross sales, and basic company functions. The ultimate phrases of the Public Providing will rely on market and different situations on the time of pricing, and there might be no assurance as as to if or when the Public Providing could also be accomplished, or as to the precise measurement or phrases of the Public Providing.

Newbridge Securities Company is performing as the only real book-running supervisor of the Public Providing.

The shares described above are being provided by ClearSign pursuant to a shelf registration assertion on Kind S-3 (File No. 333-288736) beforehand filed with and subsequently declared efficient by the Securities and Change Fee (“SEC”). A preliminary prospectus complement regarding the Public Providing has been filed with the SEC and is accessible on the SEC’s web site at http://www.sec.gov. A last prospectus complement describing the phrases of the Public Providing can be filed with the SEC. The Public Providing can be made solely by way of the prospectus complement and the accompanying base prospectus, as could also be additional supplemented by any free writing prospectus and/or pricing complement that the Firm might file with the SEC. Copies of the preliminary prospectus complement, and accompanying base prospectus regarding this Public Providing, could also be obtained from Newbridge Securities Company, Attn: Fairness Syndicate Division, 1200 North Federal Freeway, Suite 400, Boca Raton, FL 33432, electronic mail: [email protected], phone: (877) 447-9625.

This press launch shall not represent a suggestion to promote or the solicitation of a suggestion to purchase any of the securities described herein, nor shall there be any sale of those securities in any state or jurisdiction through which such provide, solicitation or sale could be illegal previous to registration or qualification beneath the securities legal guidelines of any such state or jurisdiction.

About ClearSign Applied sciences Company

ClearSign Applied sciences Company designs and develops merchandise and applied sciences for the aim of decarbonization and enhancing key efficiency traits of commercial and industrial methods, together with operational efficiency, power effectivity, emission discount, security, using hydrogen as a gasoline and general cost-effectiveness. Our patented applied sciences, embedded in established OEM merchandise as ClearSign Core^™ and ClearSign Eye^™ and different sensing configurations, improve the efficiency of combustion methods and gasoline security methods in a broad vary of markets, together with the power (upstream oil manufacturing and down-stream refining), industrial/industrial boiler, chemical, petrochemical, transport and energy industries. For extra data, please go to http://www.clearsign.com.

Cautionary Observe on Ahead-Wanting Statements

All statements on this press launch that aren’t primarily based on historic truth represent “forward-looking statements.” Such forward-looking statements contain recognized and unknown dangers, uncertainties and different elements that would trigger the precise outcomes of the Firm to be materially completely different from historic outcomes or from any future outcomes expressed or implied by such forward-looking statements. Along with statements which explicitly describe such dangers and uncertainties, readers are urged to contemplate statements containing the phrases “intends,” “estimates,” “might,” “would possibly,” “will” or different comparable expressions to be unsure and forward-looking. The Public Providing is topic to market and different situations and there might be no assurance as as to if or when the Public Providing could also be accomplished or as to the precise measurement or phrases of the Public Providing. For additional data on these and different dangers and uncertainties that will have an effect on the Firm’s enterprise, see the “Threat Elements” part of the Firm’s filings with the SEC, together with ClearSign’s Annual Report on Kind 10-Ok filed with the SEC on March 31, 2026, Quarterly Report on Kind 10-Q filed with the SEC on Might 15, 2026 and the preliminary prospectus complement filed with the SEC on Might 27, 2026. There might be no assurance that forward-looking data will show to be correct, as precise outcomes might differ materially from these anticipated in such statements. Accordingly, ClearSign cautions readers to not place undue reliance on any forward-looking statements. The Firm disclaims any intention to, and besides as could also be required by regulation, undertakes no obligation to, replace or revise forward-looking statements to replicate occasions or circumstances that subsequently happen or of which the Firm hereafter turns into conscious.

SOURCE: ClearSign Applied sciences